Trial NCT00907517

View at ClinicalTrials.gov 
Org. Study IDs: P05247
Secondary IDs: MK-8776-001

Last trial update was posted on 2018-08-27

MeSH Interventions

Cytarabine

MeSH Conditions

Leukemia Leukemia, Lymphoid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Accelerated Phase Leukemia, Myeloid, Acute Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Leukemia, Lymphocytic, Acute Myelogenous Leukemia, Acute Myelogenous Leukemia, Chronic, Aggressive Phase

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID